Interactive Educational Video for Paediatric Type 1 Diabetes
Intedu
The Efficacy of Interactive Videos in the Education of Paediatric Patients With Type 1 Diabetes: A Randomised Controlled Trial.
1 other identifier
interventional
110
0 countries
N/A
Brief Summary
The primary aim of this study is to evaluate the effectiveness of an interactive educational video (Luca's Journey: Managing Type 1 Diabetes) delivered in addition to the standard educational programme, in improving metabolic control in children with type 1 diabetes mellitus, specifically focusing on the change in glycated haemoglobin (HbA1c) levels between baseline (T0) and six-month follow-up (T3). The study will also assess the effectiveness of the intervention in improving fasting blood glucose levels, frequency of hypoglycaemic and hyperglycaemic episodes, clinical and anthropometric variables (blood pressure, body weight, BMI, and waist circumference), acquisition of nutritional knowledge based on recommendations for the management of type 1 diabetes, and adherence to the main type 1 diabetes management activities. The secondary objectives were to compare the two educational modalities (intervention vs. standard educational programme) in terms of: (i) mean between-group difference in the change in fasting blood glucose levels and frequency of hypoglycaemic and hyperglycaemic episodes; (ii) mean between-group difference in the change in clinical and anthropometric variables; (iii) acquisition of nutritional knowledge based on recommendations for the management of type 1 diabetes; and (iv) adherence to the main type 1 diabetes management activities. The main research questions addressed in this study are: Does the interactive educational video improve metabolic control, as measured by HbA1c levels, in children with type 1 diabetes compared to standard education alone? Does the intervention lead to a greater reduction in fasting blood glucose levels and a lower frequency of hypoglycaemic and hyperglycaemic episodes? Does the intervention improve clinical and anthropometric variables compared to standard education alone? Does the intervention lead to a greater acquisition of nutritional knowledge in children with type 1 diabetes? Does the intervention improve adherence to the main type 1 diabetes management activities, including insulin administration, blood glucose monitoring, dietary behaviours, and physical activity? Both study groups will receive the standard in-person educational programme, as routinely delivered at the outpatient clinic of the Regional Centre for Paediatric Diabetology of the "SS. Annunziata" University Hospital in Chieti. Participants assigned to the intervention group will additionally receive a 25-minute interactive educational video immediately following the standard educational session. The interactive video follows a child with type 1 diabetes through everyday situations, inviting participants to make decisions at key moments and explore the consequences of different behavioural choices related to diabetes management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2027
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2026
CompletedFirst Posted
Study publicly available on registry
June 10, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
Study Completion
Last participant's last visit for all outcomes
January 1, 2028
June 10, 2026
June 1, 2026
1 year
June 5, 2026
June 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in glycated haemoglobin (HbA1c) levels from baseline to 6-month follow-up
Glycated haemoglobin (HbA1c) will be assessed at baseline (T0) and at six-month follow-up (T3) using capillary blood samples collected through the glycaemic monitoring devices in use by each patient, including Continuous Glucose Monitoring Systems (CGMS) and/or Continuous Subcutaneous Insulin Infusion (CSII) devices. HbA1c reflects long-term glycaemic control over the preceding 2-3 months and is considered the primary indicator of the effectiveness of daily diabetes self-management. A clinically meaningful change is defined as a between-group difference in HbA1c greater than 0.5% (5.5 mmol/mol). Unit of Measure: Percentage points (%) of HbA1c.
Assessed at Baseline (T0) and 6 months (T3).
Secondary Outcomes (9)
Change in Fasting Blood Glucose (FBS) levels from baseline to 6-month follow-up
Assessed at baseline (T0) and 6 months (T3)
Change in Frequency of Hypoglycaemic Episodes (Mild, Moderate, and Severe) Assessed by Glycaemic Monitoring Devices or Fingerstick From Baseline to 6-Month Follow-up
Assessed at baseline (T0) and 6 months (T3)
Change in Frequency of Hyperglycaemic Episodes (Mild, Moderate, and Severe) Assessed by Glycaemic Monitoring Devices or Fingerstick From Baseline to 6-Month Follow-up
Assessed at baseline (T0) and 6 months (T3)
Change in Blood Pressure (Systolic and Diastolic) Assessed by Standard Sphygmomanometer From Baseline to 6-Month Follow-up
Assessed at baseline (T0) and 6 months (T3)
Change in Body Weight Assessed by Standard Scale From Baseline to 6-Month Follow-up
Assessed at baseline (T0) and 6 months (T3)
- +4 more secondary outcomes
Study Arms (2)
Interactive Educational Video
EXPERIMENTALParticipants assigned to the intervention group will receive, in addition to the standard educational programme, a 25-minute interactive educational video entitled Luca's Journey: Managing Type 1 Diabetes, delivered on computers available at the outpatient clinic of the Regional Centre for Paediatric Diabetology of the "SS. Annunziata" University Hospital in Chieti, on the same day as the standard educational session. The video depicts a typical day in the life of Luca, an 8-year-old child with type 1 diabetes, and covers five key aspects of paediatric diabetes management: recognising carbohydrates, managing hyperglycaemia, choosing low-sugar snacks, preparing for physical activity, and managing hypoglycaemia. At key moments, participants choose between two options, each leading to a different narrative outcome, allowing children to actively explore the consequences of different behavioural choices in everyday diabetes management situations.
Traditional face-to-face education
ACTIVE COMPARATORParticipants assigned to the control group will receive the standard in-person educational programme, as routinely delivered at the outpatient clinic of the Regional Centre for Paediatric Diabetology of the "SS. Annunziata" University Hospital in Chieti. The educational session, lasting approximately 25 minutes, will be delivered orally by a paediatric nurse with expertise in diabetology and a diabetologist. Prior to the intervention, the two professionals will hold three preliminary meetings to jointly plan the delivery of the session, defining their respective roles, timings, and the sequence of thematic areas. The session covers six key aspects of paediatric type 1 diabetes management: (i) basic information on type 1 diabetes; (ii) food and carbohydrates; (iii) nutritional labels and informed food choices; (iv) hyperglycaemia: symptoms and management; (v) management of physical activity; and (vi) hypoglycaemia: symptoms and treatment.
Interventions
The standard face-to-face educational session will be tailored to the cognitive and developmental characteristics of the target age group (8-14 years), adapting content complexity, language, and communication style to ensure comprehensibility and engagement, while maintaining consistent educational goals across participants. Understanding will be supported through verbal interaction and age-appropriate explanations provided by the paediatric nurse and diabetologist. The educational session covers six key thematic areas: basic information on type 1 diabetes, food and carbohydrates, nutritional labels and informed food choices, hyperglycaemia symptoms and management, physical activity management, and hypoglycaemia symptoms and treatment, consistent with current guidelines on diabetes management.
The interactive educational video intervention will be tailored to the cognitive and developmental characteristics of the target age group (8-14 years), adapting content complexity, language, narrative structure, and interactive elements to ensure comprehensibility and engagement, while maintaining consistent educational goals across participants. Understanding will be supported through immediate visual feedback following each interactive choice, explaining in simple terms the consequences of each behavioural option. The interactive structure of the video, based on branching narratives, will promote active learning and critical thinking.
Eligibility Criteria
You may qualify if:
- Male and female children aged between 8 and 14 years
- Diagnosis of type 1 diabetes mellitus for at least 6 months
- Ability to understand and communicate in Italian
- Absence of psychiatric disorders
- Absence of cognitive impairment
- Ability to use digital devices (e.g., computer)
- Written informed consent for study participation and personal data-processing provided by both parents or the legal guardian
You may not qualify if:
- Age younger than 8 years or older than 14 years
- Diagnosis of type 1 diabetes mellitus for less than 6 months
- Inability to understand or communicate in Italian
- Presence of psychiatric disorders
- Presence of cognitive impairment
- Inability to use digital devices (e.g., computer)
- Refusal of assent by the child
- Failure to provide written informed consent for study participation and personal data processing by both parents or the legal guardian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 5, 2026
First Posted
June 10, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Last Updated
June 10, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share